InvestorsHub Logo
Followers 47
Posts 5233
Boards Moderated 0
Alias Born 04/03/2014

Re: $heff post# 95620

Tuesday, 11/29/2016 5:47:35 PM

Tuesday, November 29, 2016 5:47:35 PM

Post# of 97237
$EGLT $heff do you know which study company is referencing in the ER conf call below? TIA.

Our Egalet-002 Phase 3 program continues to progress well as we enroll patients. We look forward to announcing results from our Egalet-002 intranasal human abuse potential study in the fourth quarter

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.